The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis
暂无分享,去创建一个
Jashanpreet Singh | K. Krishnan | C. Howden | Tusar K Desai | Kumar Krishnan | Niharika Samala | Jashanpreet Singh | John Cluley | Subaiah Perla | Colin W Howden | T. Desai | N. Samala | J. Cluley | Subaiah Perla
[1] P. A. van den Brandt,et al. Total cancer incidence and overall mortality are not increased among patients with Barrett's esophagus. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[2] A. Zinsmeister,et al. Epidemiology and Natural History of Intestinal Metaplasia of the Gastroesophageal Junction and Barrett's Esophagus: A Population-Based Study , 2011, The American Journal of Gastroenterology.
[3] A. Gavin,et al. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. , 2011, Journal of the National Cancer Institute.
[4] Prateek Sharma,et al. American Gastroenterological Association technical review on the management of Barrett's esophagus. , 2011, Gastroenterology.
[5] Amy Wang,et al. Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[6] P. Sedgwick. Meta-analyses III , 2011, BMJ : British Medical Journal.
[7] C. Jackson,et al. Surveillance in Barrett’s Esophagus: An Audit of Practice , 2010, Digestive Diseases and Sciences.
[8] A. Nagar,et al. Barrett's surveillance identifies patients with early esophageal adenocarcinoma. , 2010, The American journal of medicine.
[9] D. Alderson,et al. Long-term survival and cost analysis of an annual Barrett's surveillance programme , 2010, European journal of gastroenterology & hepatology.
[10] E. Kuipers,et al. Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[11] A. Bhattacharyya,et al. Medication usage and the risk of neoplasia in patients with Barrett's esophagus. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[12] L. Lundell,et al. Comparison of outcomes twelve years after antireflux surgery or omeprazole maintenance therapy for reflux esophagitis. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[13] P. Bampton,et al. Outcome of endoscopy surveillance for Barrett's oesophagus , 2009, ANZ journal of surgery.
[14] A. Csendes,et al. Late results of the surgical treatment of 125 patients with short-segment Barrett esophagus. , 2009, Archives of surgery.
[15] A. Charlett,et al. Treatment modality and risk of development of dysplasia and adenocarcinoma in columnar-lined esophagus. , 2009, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[16] A. Rastogi,et al. Esophageal Adenocarcinoma in Barrett's Esophagus After Endoscopic Ablative Therapy: A Meta-Analysis and Systematic Review , 2009, The American Journal of Gastroenterology.
[17] M. Vieth,et al. Critical reappraisal of current surveillance strategies for Barrett's esophagus: analysis of a large German Barrett's database. , 2008, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[18] Vicki Livingstone,et al. Barrett's esophagus: A retrospective analysis of 13 years surveillance , 2008, Journal of Gastroenterology and Hepatology.
[19] V. Lánská,et al. Low incidence of adenocarcinoma and high-grade intraepithelial neoplasia in patients with Barrett’s esophagus: a prospective cohort study , 2008, Endoscopy.
[20] L. Murray,et al. The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis. , 2008, American journal of epidemiology.
[21] J. Going,et al. Systematic Four-Quadrant Biopsy Detects Barrett's Dysplasia in More Patients Than Nonsystematic Biopsy , 2008, The American Journal of Gastroenterology.
[22] R. Greenlee,et al. Barrett's Esophagus: Incidence and Prevalence Estimates in a Rural Mid-Western Population , 2008, The American Journal of Gastroenterology.
[23] P. Moayyedi,et al. Mortality rates in patients with Barrett’s oesophagus , 2007, Alimentary pharmacology & therapeutics.
[24] B. Shadbolt,et al. Effect of proton pump inhibitors on markers of risk for high‐grade dysplasia and oesophageal cancer in Barrett’s oesophagus , 2007, Alimentary pharmacology & therapeutics.
[25] D. Forman,et al. Risk of Mortality and Cancer Incidence in Barrett's Esophagus , 2007, Cancer Epidemiology Biomarkers & Prevention.
[26] D. Treanor,et al. Low-grade dysplasia in Barrett's esophagus has a high risk of progression , 2007, Endoscopy.
[27] C. Lim1,et al. Low-grade dysplasia in Barrett's esophagus has a high risk of progression , 2007 .
[28] A. Mcintyre,et al. A surveillance programme for Barrett's oesophagus in a UK general hospital , 2007, European journal of gastroenterology & hepatology.
[29] T. Stephenson,et al. Barrett's oesophagus: Intestinal metaplasia is not essential for cancer risk , 2007, Scandinavian journal of gastroenterology.
[30] M Vieth,et al. Frequency of Barrett’s neoplasia after initial negative endoscopy with biopsy: a long-term histopathological follow-up study , 2006, Endoscopy.
[31] R. Sampliner,et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[32] B. Cooper,et al. Barrett's oesophagus: an audit of surveillance over a 17-year period , 2006, European journal of gastroenterology & hepatology.
[33] B. Cooper,et al. Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence , 2006, Alimentary pharmacology & therapeutics.
[34] M. Rugge,et al. Barrett’s epithelium after antireflux surgery , 2005, Journal of Gastrointestinal Surgery.
[35] W. Dickey,et al. Surveillance for Barrett's oesophagus: results from a programme in Northern Ireland , 2005, European journal of gastroenterology & hepatology.
[36] C. Nwokolo,et al. Barrett's surveillance is worthwhile and detects curable cancers. A prospective cohort study addressing cancer incidence, treatment outcome and survival , 2005, European journal of gastroenterology & hepatology.
[37] R. Willén,et al. Barrett Esophagus: Risk Factors for Progression to Dysplasia and Adenocarcinoma , 2005, Annals of surgery.
[38] P. Shekelle,et al. Dysplasia and Risk of Further Neoplastic Progression in a Regional Veterans Administration Barrett's Cohort , 2005, The American Journal of Gastroenterology.
[39] H. Höfler,et al. The Munich Barrett follow up study: suspicion of Barrett’s oesophagus based on either endoscopy or histology only—what is the clinical significance? , 2004, Gut.
[40] M. Solaymani-Dodaran,et al. Risk of oesophageal cancer in Barrett’s oesophagus and gastro-oesophageal reflux , 2004, Gut.
[41] J. Reynolds,et al. Long-term clinical and pathologic response of Barrett's esophagus after antireflux surgery. , 2004, American journal of surgery.
[42] A. Csendes,et al. Adenocarcinoma Appearing very late after antireflux surgery for barrett’s esophagus: long-term follow-up, review of the literature, and addition of six patients , 2004, Journal of Gastrointestinal Surgery.
[43] P. Pairolero,et al. Barrett's esophagus: the role of laparoscopic fundoplication. , 2004, The Annals of thoracic surgery.
[44] J. de Caestecker,et al. Audit of a Barrett's epithelium surveillance database , 2004, European journal of gastroenterology & hepatology.
[45] E. Kuipers,et al. Oesophageal cancer incidence and mortality in patients with long-segment Barrett's Oesophagus after a mean follow-up of 12.7 years , 2004, Scandinavian journal of gastroenterology.
[46] N. Soper,et al. Efficacy of laparoscopic antireflux surgery in patients with Barrett's esophagus. , 2003, American journal of surgery.
[47] D. Oleynikov,et al. Clinical and Pathologic Response of Barrett's Esophagus to Laparoscopic Antireflux Surgery , 2003, Annals of surgery.
[48] J. Borovička,et al. Increased detection rates of Barrett's oesophagus without rise in incidence of oesophageal adenocarcinoma. , 2003, Swiss medical weekly.
[49] A. Gavin,et al. Risk of adenocarcinoma in Barrett's oesophagus: population based study , 2003, BMJ : British Medical Journal.
[50] R. Cestari,et al. Long-term endoscopic surveillance of patients with Barrett's esophagus. incidence of dysplasia and adenocarcinoma: a prospective study , 2003, American Journal of Gastroenterology.
[51] J. Peters,et al. Barrett's esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features. , 2003, Journal of the American College of Surgeons.
[52] F. Lewis. Should we limit resident work hours? , 2003, Annals of surgery.
[53] P. Parrilla,et al. Long-Term Results of a Randomized Prospective Study Comparing Medical and Surgical Treatment of Barrett’s Esophagus , 2003, Annals of surgery.
[54] J. Hunter,et al. Clinical and histologic follow-up after antireflux surgery for Barrett’s esophagus , 2002, Journal of Gastrointestinal Surgery.
[55] R. Fitzgerald,et al. Rigorous Surveillance Protocol Increases Detection of Curable Cancers Associated with Barrett's Esophagus , 2001, Digestive Diseases and Sciences.
[56] L. Gaboury,et al. Proliferative Activity in Barrett’s Esophagus Before and After Antireflux Surgery , 2001, Annals of surgery.
[57] V. Eckardt,et al. Life expectancy and cancer risk in patients with Barrett's esophagus: a prospective controlled investigation. , 2001, The American journal of medicine.
[58] R. Sampliner,et al. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. , 2001, JAMA.
[59] D. Katzka,et al. Maximal acid reflux control for Barrett’s oesophagus: feasible and effective , 2001, Alimentary pharmacology & therapeutics.
[60] L. Melton,et al. Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota , 2001, Gut.
[61] Alex J. Sutton,et al. Methods for Meta-Analysis in Medical Research , 2000 .
[62] D. Bowrey,et al. Barrett's esophagus: a surgical disease? , 2000, The American journal of gastroenterology.
[63] S. Spechler. Barrett's esophagus: an overrated cancer risk factor. , 2000, Gastroenterology.
[64] I. Wiklund,et al. Long-term management of gastro-oesophageal reflux disease with omeprazole or open antireflux surgery: results of a prospective, randomized clinical trial. The Nordic GORD Study Group. , 2000, European journal of gastroenterology & hepatology.
[65] R. Sandler,et al. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? , 2000, Gastroenterology.
[66] Gary Longton,et al. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets , 2000, American Journal of Gastroenterology.
[67] Patricia L. Blount,et al. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. , 2000 .
[68] A. Axon,et al. Barrett's oesophagus: results from a 13‐year surveillance programme , 2000, European journal of gastroenterology & hepatology.
[69] B. Reid,et al. Effect of Segment Length on Risk for Neoplastic Progression in Patients with Barrett Esophagus , 2000, Annals of Internal Medicine.
[70] J. Dent,et al. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. , 2000, Gastroenterology.
[71] P. S. Rana,et al. Incidence of adenocarcinoma and mortality in patients with Barrett's oesophagus diagnosed between 1976 and 1986: implications for endoscopic surveillance. , 2000, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[72] M. Mayo,et al. Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia , 2000, Gut.
[73] E. Kuipers,et al. Endoscopic regression of Barrett’s oesophagus during omeprazole treatment; a randomised double blind study , 1999, Gut.
[74] Wilkinson,et al. Regression of columnar‐lined (Barrett’s) oesophagus with omeprazole 40 mg daily: results of 5 years of continuous therapy , 1999, Alimentary pharmacology & therapeutics.
[75] G. Falk,et al. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: Report on the cleveland clinic barrett's esophagus registry , 1999, American Journal of Gastroenterology.
[76] P. Aló,et al. DNA/protein flow cytometry as a predictive marker of malignancy in dysplasia-free Barrett's esophagus: thirteen-year follow-up study on a cohort of patients. , 1998, Cytometry.
[77] M. Luostarinen,et al. Histological improvement of oesophagitis after Nissen fundoplication. , 1998, Annals of medicine.
[78] Kenneth K Wang,et al. Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus , 1998, The American Journal of Gastroenterology.
[79] P. Schoenfeld,et al. Effectiveness and patient satisfaction with nurse-directed treatment of barrett's esophagus , 1998, American Journal of Gastroenterology.
[80] F. Ellis,et al. Endoscopic surveillance of barrett's esophagus: a cost-effectiveness comparison with mammographic surveillance for breast cancer , 1998, American Journal of Gastroenterology.
[81] A. Schned,et al. The Development of Dysplasia and Adenocarcinoma During Endoscopic Surveillance of Barrett's Esophagus , 1998, American Journal of Gastroenterology.
[82] G. Smith,et al. Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.
[83] G. Lapertosa,et al. Incidence of Barrett's adenocarcinoma in an Italian population: an endoscopic surveillance programme , 1997, European journal of gastroenterology & hepatology.
[84] M. Younes,et al. p53 Protein Accumulation Is a Specific Marker of Malignant Potential in Barrett's Metaplasia , 1997, Digestive Diseases and Sciences.
[85] R. Cherian,et al. Prospective long-term endoscopic and histological follow-up of short segment Barrett's esophagus: comparison with traditional long segment Barrett's esophagus. , 1997, The American journal of gastroenterology.
[86] S. Re,et al. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. , 1997 .
[87] G. Lapertosa,et al. Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole. , 1996, Gastrointestinal endoscopy.
[88] W. Hogan,et al. Barrett's ulcer: the clinical significance today. , 1996, The American journal of gastroenterology.
[89] H. Smart,et al. Cost effectiveness of detecting Barrett's cancer. , 1996, Gut.
[90] P. Pairolero,et al. Barretts's esophagus: does an antireflux procedure reduce the need for endoscopic surveillance? , 1996, The Journal of thoracic and cardiovascular surgery.
[91] G. Morales,et al. Conservative treatment versus antireflux surgery in Barrett's oesophagus: Long‐term results of a prospective study , 1996, The British journal of surgery.
[92] W. Hop,et al. Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. , 1995, Gut.
[93] C. Stoddard,et al. Regression and progression of Barrett's oesophagus after antireflux surgery , 1995, The British journal of surgery.
[94] R. Goyal,et al. Prevalence of metaplasia at the gastro-oesophageal junction , 1994, The Lancet.
[95] A. Barlow,et al. Barrett's oesophagus: Effect of antireflux surgery on symptom control and development of complications , 1992, The British journal of surgery.
[96] J. Hardcastle,et al. Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. , 1992, Gut.
[97] J. Jankowski. Adenocarcinoma and Barrett's oesophagus. , 1992, Gut.
[98] N. Walker,et al. Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. , 1991, Gut.
[99] F. Ellis,et al. Barrett's esophagus. Prevalence and incidence of adenocarcinoma. , 1991, Archives of internal medicine.
[100] S. DeMeester,et al. Surgical therapy for Barrett's esophagus. , 1990, Thoracic surgery clinics.
[101] F. Ellis,et al. Effect of antireflux operation on Barrett's mucosa. , 1990, The Annals of thoracic surgery.
[102] E. Kivilaakso,et al. Adenocarcinoma arising in Barrett's esophagus , 1989, Digestive Diseases and Sciences.
[103] J. G. van den Tweel,et al. Barrett's esophagus: development of dysplasia and adenocarcinoma. , 1989, Gastroenterology.
[104] J. Mayberry,et al. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus , 1988, The British journal of surgery.
[105] E. Achkar,et al. The cost of surveillance for adenocarcinoma complicating Barrett's esophagus. , 1988, The American journal of gastroenterology.
[106] R C Heading,et al. Barrett's oesophagus. , 1987, British medical journal.
[107] W S Payne,et al. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. , 1985, The New England journal of medicine.
[108] W G Doos,et al. Adenocarcinoma and Barrett's esophagus. An overrated risk? , 1984, Gastroenterology.
[109] Á. Lanas,et al. Trends in Barrett's esophagus diagnosis in Southern Europe: implications for surveillance. , 2009, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[110] C. Wahlen,et al. Laparoscopic treatment of Barrett’s esophagus: long-term results , 2005, Surgical Endoscopy.
[111] D. Levine,et al. Histological and anatomic changes in Barrett's esophagus after antireflux surgery , 1999, American Journal of Gastroenterology.
[112] R. Sampliner,et al. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. , 1997, The American journal of gastroenterology.
[113] K. Moghissi,et al. Adenocarcinoma and Barrett's oesophagus. A clinico-pathological study. , 1993, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[114] P. Blount,et al. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. , 1992, Gastroenterology.
[115] J. Sloan,et al. The incidence of adenocarcinoma in Barrett's oesophagus and an evaluation of endoscopic surveillance , 1991 .
[116] R. McCallum,et al. Benign Lesions of the Esophagus and Cancer , 1989, Springer Berlin Heidelberg.
[117] P. Monnier,et al. Frequency and Importance of Endobrachyesophagus in Reflux Disease , 1988 .